What is Evommune 's short-term borrowings?

Evommune (EVMN) reported short-term borrowings of $154.96K in Q4 2025.

What does short-term borrowings mean?

Bank lines of credit, revolving credit facilities, and other short-term debt instruments with maturities under one year.

Evommune EVMN Short-Term Borrowings

Short-Term Borrowings at other companies

Cabot CorporationCBT

$175M-7.9%

VontierVNT

$305.6M—

Piper SandlerPIPR

$15M0.0%

Brink's, Inc.BCO

$229.2M+65.7%

First Financial BanksharesFFIN

$22.31M-17.3%

Iridium CommunicationsIRDM

$3.4M-89.7%

Other financials

Income statement

See full

Revenue$1.6M+3.5%

Gross profit$961.1K+10.9%

Operating income-$682.8K-2,027%

Net income-$7.0M-5,414%

EPS (diluted)-$0.36-1,700%

Balance sheet

See full

Cash & equivalents$1.1M+401%

Total debt$2.0M—

Total equity-$4.5M-3,048%

Total assets$7.2M—

Cash flow

See full

Operating cash flow-$424.6K-341%

CapEx$1.0-99.8%

Free cash flow-$2.7M-4,996%

Valuation

See full

Market cap$848.59M+39.5%

Enterprise value$849.52M—

P/S127.3×—

Profitability

See full

Gross margin53.7%—

Operating margin-30.7%—

Net margin-90.1%—

Returns & leverage

See full

Return on equity275.7%—

Debt / equity1.4×—

Current ratio1.2×—

Where this comes from

Reported directly by Evommune in its filing.

Tagged under the XBRL concept us-gaap:ShortTermBorrowings.

The official record: Evommune ’s 10-K, filed March 27, 2026, on SEC EDGAR. View the filing →

Ask your AI about Evommune 's short-term borrowings.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Evommune 's short-term borrowings?: Evommune (EVMN) reported short-term borrowings of $154.96K in Q4 2025.
What does short-term borrowings mean?: Bank lines of credit, revolving credit facilities, and other short-term debt instruments with maturities under one year.